| 2026-05-12 |
13G |
0A4Y / AIM ImmunoTech Inc.
|
|
|
1,793,999 |
|
|
|
| 2026-03-05 |
13G/A |
HCTI / Healthcare Triangle, Inc.
|
|
|
2,033 |
|
|
|
| 2026-03-02 |
13G |
HCTI / Healthcare Triangle, Inc.
|
|
|
86,058 |
|
|
|
| 2026-02-05 |
13G/A |
DCX / Digital Currency X Technology Inc.
|
|
437,285 |
121,139 |
|
|
|
| 2026-02-03 |
13G/A |
ALP / Alpha Compute Corp
|
|
1,410,000 |
640,000 |
|
|
|
| 2026-01-22 |
13G/A |
SGN / Signing Day Sports, Inc.
|
|
1,409,685 |
0 |
|
|
|
| 2026-01-16 |
13G |
SGN / Signing Day Sports, Inc.
|
|
|
1,409,685 |
|
|
|
| 2026-01-16 |
13G |
ALP / Alpha Compute Corp
|
|
|
1,410,000 |
|
|
|
| 2025-12-11 |
13G/A |
PHIO / Phio Pharmaceuticals Corp.
|
|
700,421 |
538,707 |
|
|
|
| 2025-11-28 |
13G |
DCX / Digital Currency X Technology Inc.
|
|
|
437,285 |
|
|
|
| 2025-11-24 |
13G/A |
PHIO / Phio Pharmaceuticals Corp.
|
|
409,261 |
700,421 |
|
|
|
| 2025-11-12 |
13G/A |
PHIO / Phio Pharmaceuticals Corp.
|
|
800,000 |
409,261 |
|
|
|
| 2025-11-06 |
13G/A |
PHIO / Phio Pharmaceuticals Corp.
|
|
280,642 |
800,000 |
|
|
|
| 2025-10-30 |
13G/A |
CODX / Co-Diagnostics, Inc.
|
|
2,193,713 |
2,248,182 |
|
|
|
| 2025-10-30 |
13G/A |
CODX / Co-Diagnostics, Inc.
|
|
2,193,713 |
6,001,135 |
|
|
|
| 2025-09-19 |
13G/A |
CODX / Co-Diagnostics, Inc.
|
|
4,809,500 |
2,193,713 |
|
|
|
| 2025-09-18 |
13G |
CODX / Co-Diagnostics, Inc.
|
|
|
4,809,500 |
|
|
|
| 2025-09-15 |
13G/A |
SLXN / Silexion Therapeutics Corp
|
|
|
109,432 |
|
|
|
| 2025-09-15 |
13G |
SLXN / Silexion Therapeutics Corp
|
|
|
131,250 |
|
|
|
| 2025-09-09 |
13G/A |
PPBT / Purple Biotech Ltd - Depositary Receipt (Common Stock)
|
|
|
306,394 |
|
|
|
| 2025-09-09 |
13G |
PPBT / Purple Biotech Ltd - Depositary Receipt (Common Stock)
|
|
|
605,000 |
|
|
|
| 2025-08-07 |
13G/A |
PHIO / Phio Pharmaceuticals Corp.
|
|
514,965 |
280,642 |
|
|
|
| 2025-07-23 |
13G/A |
RANI / Rani Therapeutics Holdings, Inc.
|
|
4,354,000 |
1,891,623 |
|
|
|
| 2025-07-17 |
13G/A |
SXTP / 60 Degrees Pharmaceuticals, Inc.
|
|
|
166,229 |
|
|
|
| 2025-07-17 |
13G |
SXTP / 60 Degrees Pharmaceuticals, Inc.
|
|
|
320,000 |
|
|
|
| 2025-07-17 |
13G |
RANI / Rani Therapeutics Holdings, Inc.
|
|
|
4,354,000 |
|
|
|
| 2025-06-11 |
13G/A |
VERO / Venus Concept Inc.
|
|
0 |
101,748 |
|
|
|
| 2025-06-11 |
13G/A |
VERO / Venus Concept Inc.
|
|
0 |
108,680 |
|
|
|
| 2025-05-09 |
13G/A |
KTTA / Pasithea Therapeutics Corp.
|
|
|
362,857 |
|
|
|
| 2025-05-09 |
13G |
KTTA / Pasithea Therapeutics Corp.
|
|
|
371,142 |
|
|
|
| 2025-04-23 |
13G/A |
CANF / Can-Fite BioPharma Ltd. - Depositary Receipt (Common Stock)
|
|
375,000,000 |
157,382,700 |
|
|
|
| 2025-04-16 |
13G |
CANF / Can-Fite BioPharma Ltd. - Depositary Receipt (Common Stock)
|
|
|
375,000,000 |
|
|
|
| 2025-04-14 |
13G/A |
VERO / Venus Concept Inc.
|
|
|
0 |
|
|
|
| 2025-04-11 |
13G |
VERO / Venus Concept Inc.
|
|
|
83,429 |
|
|
|
| 2025-03-17 |
13G/A |
DWTX / Dogwood Therapeutics, Inc.
|
|
|
69,821 |
|
|
|
| 2025-03-17 |
13G |
DWTX / Dogwood Therapeutics, Inc.
|
|
|
115,790 |
|
|
|
| 2025-02-18 |
13G/A |
LIXT / Lixte Biotechnology Holdings, Inc.
|
|
|
120,012 |
|
|
|
| 2025-02-13 |
13G |
LIXT / Lixte Biotechnology Holdings, Inc.
|
|
|
217,392 |
|
|
|
| 2025-02-04 |
13G/A |
ENVB / Enveric Biosciences, Inc.
|
|
|
97,019 |
|
|
|
| 2025-02-04 |
13G |
ENVB / Enveric Biosciences, Inc.
|
|
|
166,667 |
|
|
|
| 2025-02-04 |
13G/A |
SPCB / SuperCom Ltd.
|
|
|
124,583 |
|
|
|
| 2025-02-03 |
13G/A |
SGLY / Singularity Future Technology Ltd.
|
|
|
0 |
|
|
|
| 2025-01-31 |
13G |
SPCB / SuperCom Ltd.
|
|
|
272,727 |
|
|
|
| 2025-01-28 |
13G |
SGLY / Singularity Future Technology Ltd.
|
|
|
233,334 |
|
|
|
| 2025-01-23 |
13G |
PHIO / Phio Pharmaceuticals Corp.
|
|
|
514,965 |
|
|
|
| 2025-01-21 |
13G/A |
BHAT / Blue Hat Interactive Entertainment Technology
|
|
9,200,000 |
0 |
|
|
|
| 2025-01-16 |
13G |
BHAT / Blue Hat Interactive Entertainment Technology
|
|
|
9,200,000 |
|
|
|